Tracked deals
9
9 tracked deals across 2026.
Minneapolis, Minnesota, United States
Vireo (Vireo Growth Inc.) is a cannabis operator founded in 2014 that cultivates and manufactures cannabis strains and products for sale through wholly owned retail dispensaries and licensed third-party dispensaries.
Tracked deals
9
9 tracked deals across 2026.
Recent pace
9
9 tracked deals announced in the last 12 months.
Deal mix
Buyout
9 buyout
Last 1 years
Supporting Data
Vireo Growth Inc. completed an all-stock court-approved plan of arrangement to acquire C21 Investments Inc. in a deal valued on an exchange basis of 0.023052 Vireo subordinate voting shares per C21 common share. The acquisition folds C21’s three Silver State Relief dispensaries and about 104,000 square feet of Nevada cultivation and production capacity into Vireo’s Nevada platform.
Vireo Growth Inc. completed its previously announced acquisition of all issued and outstanding common shares of C21 Investments Inc. under a court-approved plan of arrangement in British Columbia. C21 shareholders received 0.023052 of a Vireo subordinate voting share for each C21 common share, and the deal expands Vireo’s Nevada footprint with three Silver State Relief dispensaries and additional cultivation capacity.
C21 Investments Inc. announced that its shareholders approved the special resolution for the statutory plan of arrangement under which Vireo Growth Inc. will acquire all issued and outstanding C21 shares. Subject to customary closing conditions and regulatory/court approvals, closing is expected on or about August 21, 2026.
Vireo Growth Inc. has received all required regulatory approvals and completed its previously announced acquisition of certain Colorado retail assets of PharmaCann Inc. Total consideration was approximately $49.0 million, paid via the issuance of Vireo subordinate voting shares and the assumption of certain liabilities.
Vireo Growth Inc. entered into definitive securities purchase agreements to acquire four Ohio entities—FarmaceuticalRx LLC, FarmaceuticalRx 2 LLC, CAOH LLC, and Canoe Hill Ohio, LLC—covering eight dispensaries, a cultivation and processing facility, and related real estate. The aggregate purchase price is expected to be approximately $208 million, paid entirely in Vireo subordinate voting shares in three tranches with deferred performance-based clawbacks. Closing is expected in Q4 2026, subject to regulatory approvals and customary closing conditions.
Vireo Growth Inc. entered into a definitive merger agreement to acquire all outstanding equity interests of Planet 13 Holdings Inc. Vireo will pay consideration in the form of Vireo subordinate voting shares, representing a 16.6% premium over Planet 13’s 20-day volume-weighted average price and a 24% premium over its closing price as of July 24, 2026.
Vireo Growth Inc, through its subsidiary Vireo Health of Arcadia, LLC, entered into a definitive purchase agreement to acquire certain cannabis cultivation, manufacturing, and retail operations from subsidiaries of The Cannabist Company Holdings Inc across Colorado, Illinois, Massachusetts, New Jersey, and West Virginia. The deal consideration is up to US$35 million (subject to regulatory approvals), with closing expected in stages through 2026 and 2027. Vireo expects the transaction to add up to 25 dispensaries and strengthen its vertically integrated presence in multiple limited-license cannabis markets.
Vireo Growth Inc. entered into a definitive arrangement agreement to acquire all outstanding common shares of C21 Investments Inc. for stock consideration. The deal is expected to expand Vireo’s Nevada footprint by adding three dispensaries and approximately 104,000 sq. ft. of cultivation and production capacity.
Vireo Growth Inc. acquired Bridgewell Agribusiness LLC, a provider of organic and non-GMO food and agricultural inputs and supply chain solutions. D.A. Davidson & Co. acted as Bridgewell’s exclusive financial advisor, citing Bridgewell’s sourcing, logistics, and customer relationships as key to accelerating growth under Vireo’s ownership.
Turn tracked acquisition activity into an outreach-ready buyer list.